Last reviewed · How we verify
supersaturated calcium phosphate rinse
At a glance
| Generic name | supersaturated calcium phosphate rinse |
|---|---|
| Also known as | Caphosol |
| Sponsor | Children's Oncology Group |
| Modality | Small molecule |
| Phase | Phase 3 |
Approved indications
Common side effects
Key clinical trials
- Caphosol Study: Prevention of Oral Mucositis in Children, Adolescents and Young Adults Receiving Chemotherapy (PHASE3)
- Supersaturated Calcium Phosphate Oral Rinse (Caphosol®) For the Prevention of Oral Mucositis in Children Undergoing Chemotherapeutic Treatments (PHASE2)
- Supersaturated Calcium Phosphate Rinse in Preventing Oral Mucositis in Young Patients Undergoing Autologous or Donor Stem Cell Transplant (PHASE3)
- NeutraSal Treatment for Xerostomia in OSAS Patients Using CPAP Therapy (NA)
- Caphosol in Oral Mucositis Due to Targeted Therapy (PHASE3)
- Oral Hygiene Regimen in Patients on HCT (PHASE4)
- Caphosol® Versus State-of-the-art Mouthcare in Patients With Allogeneic Stem Cell Transplantation: a Randomized Controlled Study About the Efficacy of the Mouth Rinse Caphosol® (NA)
- Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck Cancer (PHASE1, PHASE2)
Primary sources
Every claim on this page is sourced from regulatory or scientific primary sources. See our editorial policy for full methodology.
| Source | Used for |
|---|---|
| ClinicalTrials.gov | Trial enrolment, design, endpoints, results |
Competitive intelligence
For the full competitive landscape — auto-detected comparators, recent regulatory actions across the set, upcoming PDUFA, patent timeline, sponsor landscape: